Example: confidence

Q6 BE 試験において、FDA の規制に従い実施医療機 …

Q6 BE FDA FDA 5 FDA FDA A6 21 CFR Part 320 BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS BE BA FDA 3 FDA 5 BE 5 - Retention of bioavailability samples - Retention of bioequivalence samples US US Final Rule [Retention of Bioavailability and Bioequivalence Testing Sample] Guidance for Industry "Handling and Retention of BA and BE Testing Samples BE/BA Inspection FDA FDA FDA Compliance Program Guidance Manual IN VIVO BIOEQUIVALENCE 2010 BE FDA Inspection FDA FDA483 BE FDA FDA FDA BE/BA FDA FDA Regulation FDA FDA FDA 1.

q6 : be . 試験において、 fda. の規制に従い実施医療機関にて. fda. 分析用治験薬サンプルを治験終了後. 5. 年. 間保管するよう要望されました。

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Q6 BE 試験において、FDA の規制に従い実施医療機 …

1 Q6 BE FDA FDA 5 FDA FDA A6 21 CFR Part 320 BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS BE BA FDA 3 FDA 5 BE 5 - Retention of bioavailability samples - Retention of bioequivalence samples US US Final Rule [Retention of Bioavailability and Bioequivalence Testing Sample] Guidance for Industry "Handling and Retention of BA and BE Testing Samples BE/BA Inspection FDA FDA FDA Compliance Program Guidance Manual IN VIVO BIOEQUIVALENCE 2010 BE FDA Inspection FDA FDA483 BE FDA FDA FDA BE/BA FDA FDA Regulation FDA FDA FDA 1.

2 21 CFR 2. 21 CFR 3. Final Rule [Retention of Bioavailability and Bioequivalence Testing Samples] da. gov/Sc ienceResearch/SpecialTopics/RunningClini calTrials/ucm1202 4. Guidance for Industry [Handling and Retention of BA and BE Testing Samples] 5. Compliance Program Guidance Manual IN VIVO BIOEQUIVALENCE


Related search queries